title: Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy.
authors.affiliation: Department of Oncology, Ygia Polyclinic, Limassol, Cyprus. yiorgosorphanosvp@hotmail.com
authors.forename: George S
authors.initials: GS
authors.lastname: Orphanos
authors.forename: Nicos G
authors.initials: NG
authors.lastname: Stavrou
authors.forename: Michalis K
authors.initials: MK
authors.lastname: Picolos
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001629:Bezafibrate / Q000627:therapeutic use; D000069287:Capecitabine; D002432:Cecum / Q000473:pathology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007414:Intestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging
chemical_list: D000970:Antineoplastic Agents; D000960:Hypolipidemic Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil; D001629:Bezafibrate